Related Experiment Video
Updated: May 14, 2026

A Familiarization Protocol Facilitates the Participation of Children with ASD in Electrophysiological Research
Published on: July 31, 2017
A study of consent for participation in a non-therapeutic study in the pediatric intensive care population
1Department of PICU, CHEO, , Ottawa, Ontario, Canada.
Insights
Legal guardians faced barriers like unavailability and feeling overwhelmed when consenting to paediatric critical care research. Addressing these issues is crucial for future study validity and generalizability.
Area of Science:
- Critical care medicine
- Pediatric research ethics
- Informed consent processes
Background:
- Obtaining informed consent for pediatric critical care research presents unique challenges.
- Understanding guardian-related barriers is essential for improving participation rates.
Purpose of the Study:
- To identify legal guardian-related barriers to consent procurement in a pediatric critical care research study.
- To document the reasons provided by guardians for non-participation.
Main Methods:
- A multicenter, prospective cohort study involving 1707 eligible patients.
- Data collected on consent encounters, guardian availability, language barriers, and reasons for refusal.
Main Results:
- Key barriers included guardian unavailability (321/1707) and language issues (84/1707).
- The overall consent rate was 42% among 917 approached guardians.
- Common reasons for refusal included feeling overwhelmed (117/429) and not wanting additional interventions (63/429).
Conclusions:
- Consent procurement in pediatric critical care research is hindered by multiple factors, notably guardian availability and feeling overwhelmed.
- Further research is needed to assess the impact on study validity and develop effective consent models.
Objective:
To document the legal guardian-related barriers to consent procurement, and their stated reasons for non-participation in a paediatric critical care research study.
Study Design:
A multicentre, prospective, cohort study.
Participants:
Legal guardians of children who participated in a multicentre study on adrenal insufficiency in paediatric critical illness. Data were collected on all consent encounters in the main study.
Methods:
Screening data, reasons for consent not being obtained, paediatric risk of mortality (illness severity) scores and age were collected on all 1707 patients eligible for participation in the Adrenal Insufficiency Study.
Results:
The main barriers to approaching legal guardians for consent were lack of availability of the legal guardians (321/1707) and language barriers (84/1707). Legal guardians of 917 patients were approached with an overall consent rate of 42% (range 14-56% across the seven sites). 81% of the 528 legal guardians who declined consent provided an unsolicited reason for refusal. The three most commonly stated reasons were: being overwhelmed (117/429), not wanting anything else done to their child (63/429) and not wanting an additional medication (53/429). In addition, 14.2% cited research-related concerns as the reason for their non-participation.
Conclusions:
Barriers to consent procurement in a non-therapeutic paediatric critical care study appear to occur at many levels with lack of availability of legal guardians, and legal guardians feeling overwhelmed, being the most commonly recorded reasons. Further research into the impact of these findings on the validity and generalisability of the results of such studies is necessary prior to the development and study of future consent models.
Related Concept Videos
Ethics in Research
Bioavailability Study Design: Healthy Subjects Versus Patients
Nurses' Legal Responsibilities I
The legal responsibilities of a nurse regarding informed consent include the following:
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
